Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXQ0UW
|
||||
| Drug Name |
N-((S)-3-cyclohexyl-1-((S)-1-(5-fluoroindolin-1-yl)propan-2-ylamino)-1-oxopropan-2-yl)morpholine-4-carboxamide
|
||||
| Synonyms |
CHEMBL213610
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C25H37FN4O3
|
||||
| Canonical SMILES |
C[C@@H](CN1CCc2cc(F)ccc12)NC(=O)[C@H](CC3CCCCC3)NC(=O)N4CCOCC4
|
||||
| InChI |
InChI=1S/C25H37FN4O3/c1-18(17-30-10-9-20-16-21(26)7-8-23(20)30)27-24(31)22(15-19-5-3-2-4-6-19)28-25(32)29-11-13-33-14-12-29/h7-8,16,18-19,22H,2-6,9-15,17H2,1H3,(H,27,31)(H,28,32)/t18-,22-/m0/s1
|
||||
| InChIKey |
WMOMSFMNBOGEPA-AVRDEDQJSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.